Intrepid Labs is the AI leader in pharmaceutical formulation science, dedicated to designing fit-for-purpose formulations faster, smarter, and more efficiently. Powered by decades of experience in formulation science and AIdriven automation, Intrepid Labs accelerates therapeutic development through its Valiant™ platform. This AI-driven, robotic lab compresses timelines from months to days, exploring the full formulation design space to deliver optimized, data-driven solutions supported by proprietary AI algorithms. The company is led by CEO and Co-Founder Dr. Christine Allen, a global expert in drug formulation with over 180 peer-reviewed publications. Together with co-founders Dr. Pauric Bannigan (Chief Scientific Officer) and Dr. Riley Hickman (Senior Director of Engineering), Intrepid’s leadership team leverages expertise in drug delivery, laboratory automation, and AI-driven pharmaceutical development. With multiple strategic collaborations and a growing pipeline, Intrepid sets a new standard for excellence in formulation, enabling faster, more precise, and cost-effective paths to transformative therapies.